BACKGROUND: Cardiovascular disease is a leading cause of death among renal transplant recipients. Aortic calcification is associated with increased mortality in dialysis subjects. The significance of aortic calcification among renal transplant recipients is unknown. Our objective was to prospectively examine the association of aortic calcification with cardiovascular events and all-cause mortality among asymptomatic incident renal transplant recipients. METHODS: One hundred and twelve renal transplant recipients underwent electron beam computed tomography. Aortic calcification was scored by the Agatston method. The mean follow-up time was 5.1 years. Cardiovascular events (heart failure, coronary artery disease, peripheral arterial disease and stroke) and all-cause mortality were recorded. RESULTS: The cohort consisted of 62% Caucasians, 38% African Americans and 62% male gender. The mean age was 49.0 +/- 12.5 years. Thirty-four percent had aortic calcification. During follow-up, 12 cardiovascular events and 10 deaths were recorded. Subjects with aortic calcification had more cardiovascular events compared to those without aortic calcification (23.7 versus 4.1%, P = 0.001). Recipients with aortic calcification had higher mortality compared to those without aortic calcification but it did not reach statistical significance (15.8 versus 5.4%, P = 0.07). The univariate hazard ratio of aortic calcification score in a proportional hazard Cox model to assess event-free survival was 1.15 (1.04-1.27, P = 0.01). Diabetes and aortic calcification score were independently associated with survival. In addition to the predictors above, dialysis vintage was an independent predictor for combined future cardiovascular event and mortality. CONCLUSIONS: In conclusion, aortic calcification is prevalent among renal transplant recipients and is predictive of future cardiovascular events. Aortic calcification is easily identified by non-invasive testing, and should be considered when assessing cardiovascular risk in asymptomatic renal transplant recipients.
BACKGROUND:Cardiovascular disease is a leading cause of death among renal transplant recipients. Aortic calcification is associated with increased mortality in dialysis subjects. The significance of aortic calcification among renal transplant recipients is unknown. Our objective was to prospectively examine the association of aortic calcification with cardiovascular events and all-cause mortality among asymptomatic incident renal transplant recipients. METHODS: One hundred and twelve renal transplant recipients underwent electron beam computed tomography. Aortic calcification was scored by the Agatston method. The mean follow-up time was 5.1 years. Cardiovascular events (heart failure, coronary artery disease, peripheral arterial disease and stroke) and all-cause mortality were recorded. RESULTS: The cohort consisted of 62% Caucasians, 38% African Americans and 62% male gender. The mean age was 49.0 +/- 12.5 years. Thirty-four percent had aortic calcification. During follow-up, 12 cardiovascular events and 10 deaths were recorded. Subjects with aortic calcification had more cardiovascular events compared to those without aortic calcification (23.7 versus 4.1%, P = 0.001). Recipients with aortic calcification had higher mortality compared to those without aortic calcification but it did not reach statistical significance (15.8 versus 5.4%, P = 0.07). The univariate hazard ratio of aortic calcification score in a proportional hazard Cox model to assess event-free survival was 1.15 (1.04-1.27, P = 0.01). Diabetes and aortic calcification score were independently associated with survival. In addition to the predictors above, dialysis vintage was an independent predictor for combined future cardiovascular event and mortality. CONCLUSIONS: In conclusion, aortic calcification is prevalent among renal transplant recipients and is predictive of future cardiovascular events. Aortic calcification is easily identified by non-invasive testing, and should be considered when assessing cardiovascular risk in asymptomatic renal transplant recipients.
Authors: James Li; Hannah K Galvin; Sandra C Johnson; Charles S Langston; Joy Sclamberg; Charles A Preston Journal: Chest Date: 2002-05 Impact factor: 9.410
Authors: Gregory A Nichols; Christina M Gullion; Carol E Koro; Sara A Ephross; Jonathan B Brown Journal: Diabetes Care Date: 2004-08 Impact factor: 19.112
Authors: Sharon M Moe; Kalisha D O'Neill; Naomi Fineberg; Scott Persohn; Sadiq Ahmed; Patrick Garrett; Cristopher A Meyer Journal: Nephrol Dial Transplant Date: 2003-06 Impact factor: 5.992
Authors: Craig R Walsh; L Adrienne Cupples; Daniel Levy; Douglas P Kiel; Marian Hannan; Peter W F Wilson; Christopher J O'Donnell Journal: Am Heart J Date: 2002-10 Impact factor: 4.749
Authors: Yohannes Gebreegziabher; Peter A McCullough; Chard Bubb; Lesel Loney-Hutchinson; John N Makaryus; Naveen Anand; Vijay Divakaran; Philippe Akhrass; Anis Alam; Hans von Gizycki; Samy I McFarlane Journal: Congest Heart Fail Date: 2008 May-Jun
Authors: Damiano Patrono; Robert Verhelst; Antoine Buemi; Pierre Goffette; Luc De Pauw; Nada Kanaan; Eric Goffin; Martine De Meyer; Michel Mourad Journal: World J Surg Date: 2013-07 Impact factor: 3.352
Authors: Christoph Schabel; Daniele Marin; Dominik Ketelsen; Alfredo E Farjat; Georg Bier; Mario Lescan; Fabian Bamberg; Konstantin Nikolaou; Malte N Bongers Journal: Eur Radiol Date: 2017-12-01 Impact factor: 5.315
Authors: Jasmin Prüfer; Mirjam Schuchardt; Markus Tölle; Nicole Prüfer; Matthias Höhne; Walter Zidek; Markus van der Giet Journal: PLoS One Date: 2014-07-16 Impact factor: 3.240